Clinical application of antidepressant combined with α-blocker in the treatment of chronic prostatitis
10.3969/j.issn.1005-1678.2017.07.161
- VernacularTitle:抗抑郁药联合α受体阻滞剂在治疗慢性前列腺炎中的临床应用
- Author:
Xiao XU
;
Libo MAN
;
Guizhong LI
- Keywords:
antidepressants;
α-blockers;
chronic prostatitis
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(7):391-392,395
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical effect of antidepressants combined with α-blockers in the treatment of chronic prostatitis.Methods A retrospective analysis of 90 cases of chronic prostatitis treated in our hospital from January 2016 to December 2016 was divided into two groups according to the random number table.The control group was treated with α-blocker Combined with vitamin C treatment, the study group using antidepressants combined with α-blockers treatment.The NIH-CPSI score and SDS score were recorded before and after treatment, and the therapeutic effects were compared between the two groups.Results There were no significant differences in NIH-CPSI scores and SDS scores between the two groups.After treatment, the scores of NIH-CPSI and SDS were significantly better than those before treatment, and the study group was superior to the control(91.1%) was higher than that of the control group(71.1%), the total effective rate of depression(93.3%) was higher than that of the control group(73.3%), and the total effective rate was 91.1%, The difference was statistically significant(P<0.05),comparable.Conclusion Antidepressants combined with α-blockers are effective in the treatment of chronic prostatitis, which is beneficial to the alleviation of clinical symptoms and the improvement of their symptoms.Therefore, it has a good clinical value and worthy of further popularization.
